The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription

Molecular Cell

Volumn 60, Issue 3, 2015, Pages 351-361

  Schwab, Rebekka A ^a   Nieminuszczy, Jadwiga ^a   Shah, Fenil ^b   Langton, Jamie ^a   Lopez Martinez, David ^c   Liang, Chih Chao ^c   Cohn, Martin A ^c   Gibbons, Richard J ^a   Deans, Andrew J ^b   Niedzwiedz, Wojciech ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; CARRIER PROTEIN; DNA; FANCONI ANEMIA PROTEIN; RNA; DNA HELICASE; FANCM PROTEIN, HUMAN; HETERODUPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DNA RNA HYBRIDIZATION; ENZYMATIC DEGRADATION; FANCONI ANEMIA; FEMALE; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; LEUKEMIA; MOUSE; NONHUMAN; ANIMAL; GENETICS; HELA CELL LINE; KNOCKOUT MOUSE; METABOLISM; MUTATION; PATHOLOGY;

ANIMALS; DNA DAMAGE; DNA HELICASES; DNA REPLICATION; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENOMIC INSTABILITY; HELA CELLS; HUMANS; LEUKEMIA; MICE; MICE, KNOCKOUT; MUTATION; NUCLEIC ACID HETERODUPLEXES;

EID: 84947740589     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.09.012     Document Type: Article

References (64)

1. Aguilera A., García-Muse T. R loops: from transcription byproducts to threats to genome stability. Mol. Cell 2012, 46:115-124.
2. Aguilera A., Gómez-González B. Genome instability: a mechanistic view of its causes and consequences. Nat. Rev. Genet. 2008, 9:204-217.
3. Alpi A.F., Pace P.E., Babu M.M., Patel K.J. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 2008, 32:767-777.
4. Andreassen P.R., D'Andrea A.D., Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 2004, 18:1958-1963.
5. Bhatia V., Barroso S.I., García-Rubio M.L., Tumini E., Herrera-Moyano E., Aguilera A. BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature 2014, 511:362-365.
6. Blackford A.N., Schwab R.A., Nieminuszczy J., Deans A.J., West S.C., Niedzwiedz W. The DNA translocase activity of FANCM protects stalled replication forks. Hum. Mol. Genet. 2012, 21:2005-2016.
7. Blackford A.N., Nieminuszczy J., Schwab R.A., Galanty Y., Jackson S.P., Niedzwiedz W. TopBP1 interacts with BLM to maintain genome stability but is dispensable for preventing BLM degradation. Mol. Cell 2015, 57:1133-1141.
8. Boguslawski S.J., Smith D.E., Michalak M.A., Mickelson K.E., Yehle C.O., Patterson W.L., Carrico R.J. Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J. Immunol. Methods 1986, 89:123-130.
9. Ceccaldi R., Parmar K., Mouly E., Delord M., Kim J.M., Regairaz M., Pla M., Vasquez N., Zhang Q.S., Pondarre C., et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 2012, 11:36-49.
10. Chien Y.H., Davidson N. RNA:DNA hybrids are more stable than DNA:DNA duplexes in concentrated perchlorate and trichloroacetate solutions. Nucleic Acids Res. 1978, 5:1627-1637.
11. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
12. Constantinou A. Rescue of replication failure by Fanconi anaemia proteins. Chromosoma 2012, 121:21-36.
13. Conti C., Saccà B., Herrick J., Lalou C., Pommier Y., Bensimon A. Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol. Biol. Cell 2007, 18:3059-3067.
14. Cortez D., Glick G., Elledge S.J. Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc. Natl. Acad. Sci. USA 2004, 101:10078-10083.
15. Coulthard R., Deans A.J., Swuec P., Bowles M., Costa A., West S.C., McDonald N.Q. Architecture and DNA recognition elements of the Fanconi anemia FANCM-FAAP24 complex. Structure 2013, 21:1648-1658.
16. Gan W., Guan Z., Liu J., Gui T., Shen K., Manley J.L., Li X. R-loop-mediated genomic instability is caused by impairment of replication fork progression. Genes Dev. 2011, 25:2041-2056.
17. Gari K., Décaillet C., Stasiak A.Z., Stasiak A., Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell 2008, 29:141-148.
18. González-Aguilera C., Tous C., Gómez-González B., Huertas P., Luna R., Aguilera A. The THP1-SAC3-SUS1-CDC31 complex works in transcription elongation-mRNA export preventing RNA-mediated genome instability. Mol. Biol. Cell 2008, 19:4310-4318.
19. Groh M., Gromak N. Out of balance: R-loops in human disease. PLoS Genet. 2014, 10:e1004630.
20. Heddle J.A., Lue C.B., Saunders E.F., Benz R.D. Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method. Cancer Res. 1978, 38:2983-2988.
21. Helmrich A., Ballarino M., Tora L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell 2011, 44:966-977.
22. Hira A., Yoshida K., Sato K., Okuno Y., Shiraishi Y., Chiba K., Tanaka H., Miyano S., Shimamoto A., Tahara H., et al. Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am. J. Hum. Genet. 2015, 96:1001-1007.
23. Hsu P.D., Scott D.A., Weinstein J.A., Ran F.A., Konermann S., Agarwala V., Li Y., Fine E.J., Wu X., Shalem O., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013, 31:827-832.
24. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157:1262-1278.
25. Huertas P., Aguilera A. Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol. Cell 2003, 12:711-721.
26. Kee Y., D'Andrea A.D. Molecular pathogenesis and clinical management of Fanconi anemia. J. Clin. Invest. 2012, 122:3799-3806.
27. Knipscheer P., Räschle M., Smogorzewska A., Enoiu M., Ho T.V., Schärer O.D., Elledge S.J., Walter J.C. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 2009, 326:1698-1701.
28. Kottemann M.C., Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature 2013, 493:356-363.
29. Langevin F., Crossan G.P., Rosado I.V., Arends M.J., Patel K.J. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 2011, 475:53-58.
30. Lecona E., Fernández-Capetillo O. Replication stress and cancer: it takes two to tango. Exp. Cell Res. 2014, 329:26-34.
31. Li X., Manley J.L. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 2005, 122:365-378.
32. Lossaint G., Larroque M., Ribeyre C., Bec N., Larroque C., Décaillet C., Gari K., Constantinou A. FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling. Mol. Cell 2013, 51:678-690.
33. Luebben S.W., Kawabata T., Johnson C.S., O'Sullivan M.G., Shima N. A concomitant loss of dormant origins and FANCC exacerbates genome instability by impairing DNA replication fork progression. Nucleic Acids Res. 2014, 42:5605-5615.
34. Luna R., Jimeno S., Marín M., Huertas P., García-Rubio M., Aguilera A. Interdependence between transcription and mRNP processing and export, and its impact on genetic stability. Mol. Cell 2005, 18:711-722.
35. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 2003, 35:165-170.
36. Montes de Oca R., Andreassen P.R., Margossian S.P., Gregory R.C., Taniguchi T., Wang X., Houghtaling S., Grompe M., D'Andrea A.D. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood 2005, 105:1003-1009.
37. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 2004, 15:607-620.
38. Oberbeck N., Langevin F., King G., de Wind N., Crossan G.P., Patel K.J. Maternal aldehyde elimination during pregnancy preserves the fetal genome. Mol. Cell 2014, 55:807-817.
39. Rass U., West S.C. Synthetic junctions as tools to identify and characterize Holliday junction resolvases. Methods Enzymol. 2006, 408:485-501.
40. Rickman K.A., Lach F.P., Abhyankar A., Donovan F.X., Sanborn E.M., Kennedy J.A., Sougnez C., Gabriel S.B., Elemento O., Chandrasekharappa S.C., et al. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia. Cell Rep. 2015, 12:35-41.
41. Rosado I.V., Niedzwiedz W., Alpi A.F., Patel K.J. The Walker B motif in avian FANCM is required to limit sister chromatid exchanges but is dispensable for DNA crosslink repair. Nucleic Acids Res. 2009, 37:4360-4370.
42. Rose K.M., Bell L.E., Jacob S.T. Specific inhibition of chromatin-associated poly(A) synthesis in vitro by cordycepin 5'-triphosphate. Nature 1977, 267:178-180.
43. Roy D., Zhang Z., Lu Z., Hsieh C.L., Lieber M.R. Competition between the RNA transcript and the nontemplate DNA strand during R-loop formation in vitro: a nick can serve as a strong R-loop initiation site. Mol. Cell. Biol. 2010, 30:146-159.
44. Sartori A.A., Lukas C., Coates J., Mistrik M., Fu S., Bartek J., Baer R., Lukas J., Jackson S.P. Human CtIP promotes DNA end resection. Nature 2007, 450:509-514.
45. Sato K., Ishiai M., Toda K., Furukoshi S., Osakabe A., Tachiwana H., Takizawa Y., Kagawa W., Kitao H., Dohmae N., et al. Histone chaperone activity of Fanconi anemia proteins, FANCD2 and FANCI, is required for DNA crosslink repair. EMBO J. 2012, 31:3524-3536.
46. Schlacher K., Wu H., Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 2012, 22:106-116.
47. Schwab R.A., Niedzwiedz W. Visualization of DNA replication in the vertebrate model system DT40 using the DNA fiber technique. J. Vis. Exp. 2011, 56:e3255.
48. Schwab R.A., Blackford A.N., Niedzwiedz W. ATR activation and replication fork restart are defective in FANCM-deficient cells. EMBO J. 2010, 29:806-818.
49. Seki S., Ohzeki M., Uchida A., Hirano S., Matsushita N., Kitao H., Oda T., Yamashita T., Kashihara N., Tsubahara A., et al. A requirement of FancL and FancD2 monoubiquitination in DNA repair. Genes Cells 2007, 12:299-310.
50. Shen B., Zhang W., Zhang J., Zhou J., Wang J., Chen L., Wang L., Hodgkins A., Iyer V., Huang X., Skarnes W.C. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat. Methods 2014, 11:399-402.
51. Sirbu B.M., Couch F.B., Feigerle J.T., Bhaskara S., Hiebert S.W., Cortez D. Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev. 2011, 25:1320-1327.
52. Skourti-Stathaki K., Proudfoot N.J. A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression. Genes Dev. 2014, 28:1384-1396.
53. Skourti-Stathaki K., Proudfoot N.J., Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol. Cell 2011, 42:794-805.
54. Sollier J., Stork C.T., García-Rubio M.L., Paulsen R.D., Aguilera A., Cimprich K.A. Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Mol. Cell 2014, 56:777-785.
55. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002, 100:2414-2420.
56. Tresini M., Warmerdam D.O., Kolovos P., Snijder L., Vrouwe M.G., Demmers J.A., van IJcken W.F., Grosveld F.G., Medema R.H., Hoeijmakers J.H., et al. The core spliceosome as target and effector of non-canonical ATM signalling. Nature 2015, 523:53-58.
57. Tuduri S., Crabbé L., Conti C., Tourrière H., Holtgreve-Grez H., Jauch A., Pantesco V., De Vos J., Thomas A., Theillet C., et al. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat. Cell Biol. 2009, 11:1315-1324.
58. Tuschl T. Cotransfection of luciferase reporter plasmids with siRNA duplexes. CSH Protoc. 2006, Published online June 1, 2006. 10.1101/pdb.prot4342.
59. Wagner J.M., Karnitz L.M. Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival. Mol. Pharmacol. 2009, 76:208-214.
60. Walden H., Deans A.J. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Annu. Rev. Biophys. 2014, 43:257-278.
61. Walter D., Lier A., Geiselhart A., Thalheimer F.B., Huntscha S., Sobotta M.C., Moehrle B., Brocks D., Bayindir I., Kaschutnig P., et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 2015, 520:549-552.
62. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 2007, 8:735-748.
63. Xue Y., Li Y., Guo R., Ling C., Wang W. FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet. 2008, 17:1641-1652.
64. Yu K., Chedin F., Hsieh C.L., Wilson T.E., Lieber M.R. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 2003, 4:442-451.